Skip to content

A randomized controlled trial comparing intermittent erector spinae plane block versus single shot intercostal block (SSIB) in video-assisted thoracoscopic surgery (VATS) of wedge resection and lobectomies

A randomized controlled trial comparing intermittent erector spinae plane block versus single shot intercostal block (SSIB) in video-assisted thoracoscopic surgery (VATS) of wedge resection and lobectomies - ESPERANTO

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46023
Enrollment
77
Registered
2018-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

surgery of lung tumours

Interventions

Single Shot Intercostal Block versus intermittent Erector Spinae Plane Block

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult patient older than 18 years undergoing elective unilateral VATS for wedge resection, lobectomy, biopsy, resection of a nodule, or bullectomy. Patients must be able and willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: Participation in another trial focusing on postoperative recovery - Allergy to local anesthetics or morphine - Refusal of one of the methods of analgesia - Insufficient comprehension of the Dutch QoR-40 questionaire. - Chronic pain, or opioid use longer than 3 months

Design outcomes

Primary

MeasureTime frame
QoR-40 score at day 2.

Secondary

MeasureTime frame
QoR-40 at day 1 and 3, postoperative morphine-equivalent consumption per day until discharge, postoperative NRS (Numeric Rating Scale) score day 1-3 (mean and maximum per day), postoperative VAS score (Visual Analog Scale, mean and maximum per day) day 1-3, LOS (Length of hospital stay), requirement of rescue medication, sensory block spread immediately postoperatively and on POD 1 and 2, side effects unrelated to surgery, surgical site infection, postoperative pneumonia, LA toxicity (epileptic seizures).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)